Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three-year experience

Beverly Barton Rogers, John Sommerauer, Albert Quan, Charles F. Timmons, D. Brian Dawson, Richard H. Scheuermann, Karen Krisher, Carolyn Atkins

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To assess whether the semiquantitative peripheral blood Epstein-Barr virus (EBV) polymerase chain reaction (PCR) test correlates with post-transplant lymphoproliferative disorder (LPD), we compiled the results of the test done over a 3-year period ending July 1997. Six hundred seventy-six tests were done on 185 patients. Four hundred-thirty tests (63%) were negative, 167 (25%) were weak positive, 67 (10%) were moderate positive, and 12 (2%) were strong positive. Twelve of the patients developed a lymphoproliferative disorder (LPD) during this time. The EBV PCR tests proximate to the diagnosis of LPD in the 12 patients with EBV-positive LPD were 6 strong positive, 5 moderate positive, 1 weak positive. No patient with LPD had a negative result at diagnosis. Stated another way, 6/12 (50%) of strong-positive PCR tests, 5/67 (7%) moderate-positive tests, and 1/167 (.6%) of weak-positive tests correlated with LPD. Serologic evaluation for EBV done on 7 patients at the time of LPD showed low serologic responses in 5 of the 7 patients. The EBV PCR temporally associated with the serology indicated moderate to large viral burdens. In each patient evaluated serially, the EBV PCR test rose before the diagnosis of LPD and fell with treatment for the disorder. In conclusion, the EBV PCR test may be used as an adjunct to the diagnosis of patients with LPD and may be used to monitor response to therapy for the disorder.

Original languageEnglish (US)
Pages (from-to)480-486
Number of pages7
JournalPediatric and Developmental Pathology
Volume1
Issue number6
StatePublished - Nov 1998

Fingerprint

Lymphoproliferative Disorders
Serology
Human Herpesvirus 4
Pediatrics
Transplants
Polymerase Chain Reaction
Viral Load

Keywords

  • Epstein-Barr virus
  • Lymphoproliferative disorder
  • Polymerase chain reaction
  • Serology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder : Three-year experience. / Rogers, Beverly Barton; Sommerauer, John; Quan, Albert; Timmons, Charles F.; Dawson, D. Brian; Scheuermann, Richard H.; Krisher, Karen; Atkins, Carolyn.

In: Pediatric and Developmental Pathology, Vol. 1, No. 6, 11.1998, p. 480-486.

Research output: Contribution to journalArticle

Rogers, BB, Sommerauer, J, Quan, A, Timmons, CF, Dawson, DB, Scheuermann, RH, Krisher, K & Atkins, C 1998, 'Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three-year experience', Pediatric and Developmental Pathology, vol. 1, no. 6, pp. 480-486.
Rogers, Beverly Barton ; Sommerauer, John ; Quan, Albert ; Timmons, Charles F. ; Dawson, D. Brian ; Scheuermann, Richard H. ; Krisher, Karen ; Atkins, Carolyn. / Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder : Three-year experience. In: Pediatric and Developmental Pathology. 1998 ; Vol. 1, No. 6. pp. 480-486.
@article{d08abfee1e8b45cabde91b0818f76503,
title = "Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three-year experience",
abstract = "To assess whether the semiquantitative peripheral blood Epstein-Barr virus (EBV) polymerase chain reaction (PCR) test correlates with post-transplant lymphoproliferative disorder (LPD), we compiled the results of the test done over a 3-year period ending July 1997. Six hundred seventy-six tests were done on 185 patients. Four hundred-thirty tests (63{\%}) were negative, 167 (25{\%}) were weak positive, 67 (10{\%}) were moderate positive, and 12 (2{\%}) were strong positive. Twelve of the patients developed a lymphoproliferative disorder (LPD) during this time. The EBV PCR tests proximate to the diagnosis of LPD in the 12 patients with EBV-positive LPD were 6 strong positive, 5 moderate positive, 1 weak positive. No patient with LPD had a negative result at diagnosis. Stated another way, 6/12 (50{\%}) of strong-positive PCR tests, 5/67 (7{\%}) moderate-positive tests, and 1/167 (.6{\%}) of weak-positive tests correlated with LPD. Serologic evaluation for EBV done on 7 patients at the time of LPD showed low serologic responses in 5 of the 7 patients. The EBV PCR temporally associated with the serology indicated moderate to large viral burdens. In each patient evaluated serially, the EBV PCR test rose before the diagnosis of LPD and fell with treatment for the disorder. In conclusion, the EBV PCR test may be used as an adjunct to the diagnosis of patients with LPD and may be used to monitor response to therapy for the disorder.",
keywords = "Epstein-Barr virus, Lymphoproliferative disorder, Polymerase chain reaction, Serology",
author = "Rogers, {Beverly Barton} and John Sommerauer and Albert Quan and Timmons, {Charles F.} and Dawson, {D. Brian} and Scheuermann, {Richard H.} and Karen Krisher and Carolyn Atkins",
year = "1998",
month = "11",
language = "English (US)",
volume = "1",
pages = "480--486",
journal = "Pediatric and Developmental Pathology",
issn = "1093-5266",
publisher = "Society for Pediatric Pathology",
number = "6",

}

TY - JOUR

T1 - Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder

T2 - Three-year experience

AU - Rogers, Beverly Barton

AU - Sommerauer, John

AU - Quan, Albert

AU - Timmons, Charles F.

AU - Dawson, D. Brian

AU - Scheuermann, Richard H.

AU - Krisher, Karen

AU - Atkins, Carolyn

PY - 1998/11

Y1 - 1998/11

N2 - To assess whether the semiquantitative peripheral blood Epstein-Barr virus (EBV) polymerase chain reaction (PCR) test correlates with post-transplant lymphoproliferative disorder (LPD), we compiled the results of the test done over a 3-year period ending July 1997. Six hundred seventy-six tests were done on 185 patients. Four hundred-thirty tests (63%) were negative, 167 (25%) were weak positive, 67 (10%) were moderate positive, and 12 (2%) were strong positive. Twelve of the patients developed a lymphoproliferative disorder (LPD) during this time. The EBV PCR tests proximate to the diagnosis of LPD in the 12 patients with EBV-positive LPD were 6 strong positive, 5 moderate positive, 1 weak positive. No patient with LPD had a negative result at diagnosis. Stated another way, 6/12 (50%) of strong-positive PCR tests, 5/67 (7%) moderate-positive tests, and 1/167 (.6%) of weak-positive tests correlated with LPD. Serologic evaluation for EBV done on 7 patients at the time of LPD showed low serologic responses in 5 of the 7 patients. The EBV PCR temporally associated with the serology indicated moderate to large viral burdens. In each patient evaluated serially, the EBV PCR test rose before the diagnosis of LPD and fell with treatment for the disorder. In conclusion, the EBV PCR test may be used as an adjunct to the diagnosis of patients with LPD and may be used to monitor response to therapy for the disorder.

AB - To assess whether the semiquantitative peripheral blood Epstein-Barr virus (EBV) polymerase chain reaction (PCR) test correlates with post-transplant lymphoproliferative disorder (LPD), we compiled the results of the test done over a 3-year period ending July 1997. Six hundred seventy-six tests were done on 185 patients. Four hundred-thirty tests (63%) were negative, 167 (25%) were weak positive, 67 (10%) were moderate positive, and 12 (2%) were strong positive. Twelve of the patients developed a lymphoproliferative disorder (LPD) during this time. The EBV PCR tests proximate to the diagnosis of LPD in the 12 patients with EBV-positive LPD were 6 strong positive, 5 moderate positive, 1 weak positive. No patient with LPD had a negative result at diagnosis. Stated another way, 6/12 (50%) of strong-positive PCR tests, 5/67 (7%) moderate-positive tests, and 1/167 (.6%) of weak-positive tests correlated with LPD. Serologic evaluation for EBV done on 7 patients at the time of LPD showed low serologic responses in 5 of the 7 patients. The EBV PCR temporally associated with the serology indicated moderate to large viral burdens. In each patient evaluated serially, the EBV PCR test rose before the diagnosis of LPD and fell with treatment for the disorder. In conclusion, the EBV PCR test may be used as an adjunct to the diagnosis of patients with LPD and may be used to monitor response to therapy for the disorder.

KW - Epstein-Barr virus

KW - Lymphoproliferative disorder

KW - Polymerase chain reaction

KW - Serology

UR - http://www.scopus.com/inward/record.url?scp=0032200375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032200375&partnerID=8YFLogxK

M3 - Article

C2 - 9724334

AN - SCOPUS:0032200375

VL - 1

SP - 480

EP - 486

JO - Pediatric and Developmental Pathology

JF - Pediatric and Developmental Pathology

SN - 1093-5266

IS - 6

ER -